Found: 5
Select item for more details and to access through your institution.
C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation.
- Published in:
- Nature Communications, 2016, v. 7, n. 2, p. 10346, doi. 10.1038/ncomms10346
- By:
- Publication type:
- Article
Prevention of Arthritis by Locally Synthesized Recombinant Antibody Neutralizing Complement Component C5.
- Published in:
- PLoS ONE, 2013, v. 8, n. 3, p. 1, doi. 10.1371/journal.pone.0058696
- By:
- Publication type:
- Article
Targeted Delivery of Neutralizing Anti-C5 Antibody to Renal Endothelium Prevents Complement-Dependent Tissue Damage.
- Published in:
- Frontiers in Immunology, 2017, p. 1, doi. 10.3389/fimmu.2017.01093
- By:
- Publication type:
- Article
Multiple-Organ Complement Deposition on Vascular Endothelium in COVID-19 Patients.
- Published in:
- Biomedicines, 2021, v. 9, n. 8, p. 1003, doi. 10.3390/biomedicines9081003
- By:
- Publication type:
- Article
A novel complement-fixing IgM antibody targeting GPC1 as a useful immunotherapeutic strategy for the treatment of pancreatic ductal adenocarcinoma.
- Published in:
- Journal of Translational Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12967-023-04745-9
- By:
- Publication type:
- Article